{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:27:48Z","timestamp":1789982868329,"version":"4.0.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2078,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.bbmt.2009.04.004","type":"journal-article","created":{"date-parts":[[2009,6,11]],"date-time":"2009-06-11T05:59:16Z","timestamp":1244699956000},"page":"919-929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Graft-versus-Host Disease Prophylaxis with Tacrolimus and Mycophenolate Mofetil in HLA-Matched Nonmyeloablative Transplant Recipients Is Associated with Very Low Incidence of GVHD and Nonrelapse Mortality"],"prefix":"10.1016","volume":"15","author":[{"given":"Waleed","family":"Sabry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Le Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie-Claude","family":"Labb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Sauvageau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Couban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambert","family":"Busque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvy","family":"Lachance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis-Claude","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2009.04.004_bib1","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1200\/JCO.1998.16.8.2817","article-title":"Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies","volume":"16","author":"Khouri","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2009.04.004_bib2","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.04.004_bib3","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1056\/NEJM200009143431101","article-title":"Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation","volume":"343","author":"Childs","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2009.04.004_bib4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.bmt.1703215","article-title":"A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome","volume":"28","author":"Kroger","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.04.004_bib5","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1200\/JCO.2001.19.14.3340","article-title":"Allogeneic hematopoietic stem cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome","volume":"19","author":"Michallet","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2009.04.004_bib6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.bmt.1704767","article-title":"Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning","volume":"35","author":"Flowers","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.04.004_bib7","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/sj.bmt.1705987","article-title":"Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimens","volume":"41","author":"Sala-Torra","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.04.004_bib8","first-page":"2303","article-title":"Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation","volume":"92","author":"Ratanatharathorn","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.04.004_bib9","first-page":"2062","article-title":"Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors","volume":"96","author":"Nash","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.04.004_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.bmt.1703097","article-title":"Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation","volume":"28","author":"Hiraoka","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.04.004_bib11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.exphem.2005.09.013","article-title":"Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation","volume":"34","author":"Dh\u00e9din","year":"2006","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2009.04.004_bib12","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.bbmt.2009.04.004_bib13","first-page":"825","article-title":"1994 Consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.04.004_bib14","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"12","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.04.004_bib15","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.bbmt.2007.06.013","article-title":"High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation","volume":"13","author":"Labb\u00e9","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.04.004_bib16","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1128\/JCM.38.12.4356-4360.2000","article-title":"Quantitative analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay and the COBAS AMPLICOR CMV MONITOR PCR test after blood and marrow allogeneic transplantation","volume":"38","author":"Boivin","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bbmt.2009.04.004_bib17","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","article-title":"Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy","volume":"89","author":"Giralt","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.04.004_bib18","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1182\/blood.V94.9.3234","article-title":"Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses","volume":"94","author":"Childs","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.04.004_bib19","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1182\/blood.V97.11.3390","article-title":"Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects","volume":"97","author":"McSweeney","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.04.004_bib20","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1182\/blood-2004-06-2275","article-title":"Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma","volume":"104","author":"Maris","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.04.004_bib21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/157488807780599248","article-title":"Reduced-intensity stem cell transplantation for hematological malignancies: current status and the future","volume":"2","author":"Kato","year":"2007","journal-title":"Curr Stem Cell Res Ther"},{"key":"10.1016\/j.bbmt.2009.04.004_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1200\/JCO.2007.11.5477","article-title":"Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma","volume":"26","author":"Rezvani","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2009.04.004_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ajh.1051","article-title":"Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens","volume":"66","author":"Ruiz-Arg\u00fcelles","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2009.04.004_bib24","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/sj.bmt.1704254","article-title":"Allogeneic stem cell transplantation with reduced-intensity conditioning is potentially feasible as an outpatient procedure","volume":"32","author":"Subir\u00e0","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.04.004_bib25","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1182\/blood.V98.13.3595","article-title":"Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality","volume":"98","author":"Khouri","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.04.004_bib26","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1182\/blood-2004-05-1947","article-title":"Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age","volume":"105","author":"Alyea","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.04.004_bib27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bbmt.2005.04.002","article-title":"Reduced-intensity allogenec stem cell transplantation in adults and children with malignant and nonmalignant diseases; end of the beginning and future challenges","volume":"11","author":"Satwani","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.04.004_bib28","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.7164\/antibiotics.40.1256","article-title":"FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro","volume":"40","author":"Kino","year":"1987","journal-title":"J Antibiot"},{"key":"10.1016\/j.bbmt.2009.04.004_bib29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bbmt.2005.02.006","article-title":"Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens","volume":"11","author":"Cutler","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.04.004_bib30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1034\/j.1399-0012.2000.140204.x","article-title":"Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients","volume":"14","author":"Basara","year":"2000","journal-title":"Clin Transplant"},{"key":"10.1016\/j.bbmt.2009.04.004_bib31","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/sj.bmt.1703076","article-title":"Mycophenolate mofetil for the prevention and treatment of graft-versus-host disease following stem cell transplantation: preliminary findings","volume":"27","author":"Vogelsang","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.04.004_bib32","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/sj.bmt.1704640","article-title":"Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation","volume":"34","author":"Mohty","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.04.004_bib33","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.bmt.1704956","article-title":"Cyclosporine A and mycophenolate mofetil vs cyclosporine A and methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings","volume":"35","author":"Neumann","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.04.004_bib34","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bbmt.2005.03.006","article-title":"A phase I\/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation","volume":"11","author":"Nash","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.04.004_bib35","first-page":"364","article-title":"Therapeutic synergism between low-dose FK-506 and antimetabolites in rat allogeneic heart transplantation","volume":"27","author":"Tanabe","year":"1995","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2009.04.004_bib36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0966-3274(97)80042-1","article-title":"Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings","volume":"5","author":"Zucker","year":"1997","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.bbmt.2009.04.004_bib37","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/00007890-199911270-00028","article-title":"Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients","volume":"68","author":"Gregoor","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2009.04.004_bib38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00007691-200104000-00005","article-title":"Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid","volume":"23","author":"van Gelder","year":"2001","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.bbmt.2009.04.004_bib39","first-page":"714a","article-title":"Favorable early transplant outcomes using tacrolimus and mycophenolate mofetil for GVHD prevention after matched sibling allografting","volume":"102","author":"McSweeney","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.04.004_bib40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bbmt.2005.10.012","article-title":"Tacrolimus and mycophenolate mofetil after nonmyeloablative matched-sibling donor allogeneic stem-cell transplantations conditioned with fludarabine and low-dose total body irradiation","volume":"12","author":"Nieto","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.04.004_bib41","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/ajh.20862","article-title":"Mixed chimerism and graft failure following conditioning with the fludarabine and cyclophosphamide nonablative regimen; conversion to full donor chimerism","volume":"82","author":"Jillella","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2009.04.004_bib42","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/ajh.20990","article-title":"Nonmyeloablative allogeneic stem cell transplantation in elderly patients with hematological malignancies: results from the GITMO (Gruppo Italiano Trapianto Midollo Osseo) multicenter prospective clinical trial","volume":"82","author":"Falda","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2009.04.004_bib43","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.bbmt.2005.06.006","article-title":"Nonmyeloablative stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia in patients 60 years or older","volume":"11","author":"Gupta","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.04.004_bib44","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood-2002-08-2628","article-title":"Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation","volume":"102","author":"Mielcarek","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.04.004_bib45","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.bbmt.2007.03.002","article-title":"Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy","volume":"13","author":"Koh","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.04.004_bib46","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2141.2005.05614.x","article-title":"Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation","volume":"130","author":"P\u00e9rez-Sim\u00f3n","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2009.04.004_bib47","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/01.tp.0000203556.06145.5b","article-title":"Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation","volume":"81","author":"Burroughs","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2009.04.004_bib48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00007890-199807150-00015","article-title":"Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen","volume":"66","author":"Manilay","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2009.04.004_bib49","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1182\/blood-2004-04-1506","article-title":"Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning","volume":"104","author":"Baron","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.04.004_bib50","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0016-5085(86)90949-2","article-title":"Intestinal and hepatic complications of human bone marrow transplantation","volume":"90","author":"McDonald","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbmt.2009.04.004_bib51","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/bbmt.2003.49999","article-title":"Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study","volume":"9","author":"Akpek","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.04.004_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.dad.0000246173.96318.0c","article-title":"Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease","volume":"29","author":"Bridge","year":"2007","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.bbmt.2009.04.004_bib53","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.leu.2404642","article-title":"Chronic graft-versus-host disease in the era of reduced-intensity conditioning","volume":"21","author":"Subramaniam","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2009.04.004_bib54","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1080\/10428190500125754","article-title":"Graft-vs-host disease after non-myeloablative hematopoietic cell transplantation","volume":"46","author":"Mielcarek","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2009.04.004_bib55","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1182\/blood-2004-01-0200","article-title":"Duration of immunosuppressive treatment for chronic graft-versus-host disease","volume":"104","author":"Stewart","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.04.004_bib56","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2141.2004.04897.x","article-title":"Haematopoietic stem cell transplantation with non-myeloablative conditioning in the outpatient setting: results, complications and admission requirements in a single institution","volume":"125","author":"Petersen","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2009.04.004_bib57","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbmt.2003.10.006","article-title":"Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation","volume":"10","author":"Couriel","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.04.004_bib58","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1182\/blood.V90.8.3204","article-title":"Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines","volume":"90","author":"Hill","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.04.004_bib59","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1172\/JCI4285","article-title":"Tumor necrosis factor-alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease","volume":"102","author":"Cooke","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2009.04.004_bib60","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1182\/blood.V88.12.4601.bloodjournal88124601","article-title":"Mechanism for cotolerance in nonlethally conditioned mixed chimeras: negative selection of the Vbeta T-cell receptor repertoire by both host and donor bone marrow-derived cells","volume":"88","author":"Colson","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.04.004_bib61","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1126\/science.285.5426.412","article-title":"Prevention of graft versus host disease by inactivation of host antigen-presenting cells","volume":"285","author":"Shlomchik","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2009.04.004_bib62","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1182\/blood-2002-05-1340","volume":"101","author":"Niederwieser","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.04.004_bib63","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1182\/blood-2002-04-1150","article-title":"Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality","volume":"100","author":"Kroger","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.04.004_bib64","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.bmt.1703652","article-title":"Fludarabine\/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma","volume":"30","author":"Giralt","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.04.004_bib65","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/sj.bmt.1704531","article-title":"Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation","volume":"34","author":"Mohty","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.04.004_bib66","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1200\/JCO.2005.08.136","article-title":"Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning","volume":"23","author":"Baron","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879109001888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879109001888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:33:35Z","timestamp":1761057215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879109001888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":66,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S1083879109001888"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2009.04.004","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Graft-versus-Host Disease Prophylaxis with Tacrolimus and Mycophenolate Mofetil in HLA-Matched Nonmyeloablative Transplant Recipients Is Associated with Very Low Incidence of GVHD and Nonrelapse Mortality","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2009.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}